Clinical trial Recruiting at 1 site Observational Ages 19 and up

Acute Heart Failure: How a Quantitative ECG Helps Clinicians

Official title: Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study

Run by Seoul National University Bundang Hospital · NCT07601022 · Data updated 2026-11-12

This study tests whether quantitative ECG (QCG) measurements can reveal useful patterns in adults hospitalized with acute heart failure.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment400 (estimated)
SponsorSeoul National University Bundang Hospital
Academic / other
Locations1 site (Seongnam-si, Gyeonggi-do)
StatusRecruiting
StartedMay 8, 2026
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedJune 1, 2026
Trial IDNCT07601022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 or older hospitalized for acute heart failure who have an ECG and NT-proBNP ≥300 pg/mL.

Probably not a fit

Patients with congenital heart disease, dominant electronic pacemakers, very high heart rates, or excessively noisy ECGs may not benefit from QCG analyses.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes the associations between quantitative electrocardiography (QCG) measurements and clinical and laboratory data in patients admitted with acute heart failure. Adults 19 or older who meet NT-proBNP criteria and have had an ECG are included, while those with congenital heart disease, dominant pacemakers, very high heart rates, or noisy ECGs are excluded. The goal is to understand how QCG features relate to patient characteristics and lab results to improve clinical insight. The work is conducted at Seoul National University Bundang Hospital under the lead sponsor Jin Joo Park with no listed collaborators.

Why it matters

Potential benefit: If successful, QCG insights could help clinicians better interpret ECGs and tailor management for acute heart failure patients.

How similar studies have gone: Previous work in related cardiac populations suggests QCG holds promise for uncovering meaningful associations, though precise benefits in acute heart failure require confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
* NT-proBNP ≥300 pg/mL
* Patients who underwent electrocardiography at least once

Exclusion Criteria:

* History of congenital heart disease
* Patients with a dominant electronic pacemaker rhythm
* Patients with a heart rate \>140 beats per minute or electrocardiograms with excessive noise

Where it's running

  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do, South Korea
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.